12.19
Ginkgo Bioworks Holdings Inc stock is traded at $12.19, with a volume of 1.35M.
It is down -7.23% in the last 24 hours and up +7.31% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
See More
Previous Close:
$13.14
Open:
$12.42
24h Volume:
1.35M
Relative Volume:
0.99
Market Cap:
$564.94M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-0.9384
EPS:
-12.99
Net Cash Flow:
$-387.26M
1W Performance:
-12.68%
1M Performance:
+7.31%
6M Performance:
-8.76%
1Y Performance:
-17.64%
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Compare DNA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
DNA
Ginkgo Bioworks Holdings Inc
|
12.19 | 769.11M | 217.11M | -651.19M | -387.26M | -12.99 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
Nov-29-22 | Initiated | Berenberg | Buy |
Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
Mar-02-22 | Resumed | Cowen | Outperform |
Feb-23-22 | Initiated | Goldman | Neutral |
Feb-01-22 | Initiated | BofA Securities | Neutral |
Jan-28-22 | Initiated | BofA Securities | Buy |
Jan-07-22 | Initiated | BTIG Research | Buy |
Nov-29-21 | Initiated | Jefferies | Buy |
Oct-13-21 | Initiated | Raymond James | Outperform |
Oct-12-21 | Initiated | William Blair | Outperform |
Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
Is Ginkgo Bioworks Holdings Inc. stock overvalued or undervaluedBeginner Investor Watchlist For 2025 - jammulinksnews.com
Ginkgo Bioworks shares fall 6.39% premarket ahead of Q2 2025 earnings presentation. - AInvest
Ginkgo Bioworks awarded $4.66M contract by PNNL - Yahoo Finance
Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation - 富途牛牛
Ginkgo Bioworks Q2 Earnings: Biosecurity Leader Sets August 7 Investor Call with Interactive Q&A - Stock Titan
How does Ginkgo Bioworks Holdings Inc. compare to its industry peersWealth Building Guidance For Smart Trading - jammulinksnews.com
Does Ginkgo Bioworks Holdings Inc. stock perform well during market downturnsSmart Portfolio Planner For Beginners - jammulinksnews.com
Ginkgo Bioworks stock rises after securing $4.66M automation contract By Investing.com - Investing.com Canada
Ginkgo Bioworks Secures $4.66M Federal Contract for Revolutionary Lab Automation System at PNNL - Stock Titan
What makes Ginkgo Bioworks Holdings Inc. stock price move sharplyRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Ginkgo Bioworks Holdings Inc. Flashes Rebound Signal in Oversold ConditionInvestment Plan With Growth Optimization Finalized - metal.it
Ginkgo Bioworks Holdings Inc. Stock Flags Risk Zone in Volatility IndexEarly Breakout Entry Point Notifications Sent - beatles.ru
Ginkgo Bioworks Holdings Inc. Breaks Below Key Support LevelSecure Capital Picks With Upside Potential Tracked - metal.it
What are analysts’ price targets for Ginkgo Bioworks Holdings Inc. in the next 12 monthsMaximize gains with proven stock analysis - jammulinksnews.com
What is the dividend policy of Ginkgo Bioworks Holdings Inc. stockSwing Trade Updates For Consistent Profits - jammulinksnews.com
How strong is Ginkgo Bioworks Holdings Inc. company’s balance sheetStay informed with daily expert analysis - jammulinksnews.com
When is Ginkgo Bioworks Holdings Inc. stock expected to show significant growthTop Growth Watchlist For 2025 - jammulinksnews.com
What are the latest earnings results for Ginkgo Bioworks Holdings Inc.Achieve rapid portfolio appreciation today - jammulinksnews.com
What catalysts could drive Ginkgo Bioworks Holdings Inc. stock higher in 2025High-octane financial growth - jammulinksnews.com
What institutional investors are buying Ginkgo Bioworks Holdings Inc. stockAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
Should I hold or sell Ginkgo Bioworks Holdings Inc. stock in 2025Accelerated capital growth - jammulinksnews.com
Ginkgo Bioworks Stock (DNA) Opinions on New Product Launch and Earnings Anticipation - Quiver Quantitative
Why Ginkgo Bioworks Holdings Inc. stock attracts strong analyst attentionEarly Breakout Tracker - beatles.ru
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know - MSN
What drives Ginkgo Bioworks Holdings Inc. stock priceDynamic investment opportunities - PrintWeekIndia
Is Ginkgo Bioworks Holdings Inc. a good long term investmentPhenomenal wealth increase - PrintWeekIndia
What analysts say about Ginkgo Bioworks Holdings Inc. stockMarket-beating performance - Autocar Professional
How high can Ginkgo Bioworks Holdings Inc. stock price go in 2025Free Stock Market Trend Analysis - jammulinksnews.com
Stocks To Watch: Ginkgo Bioworks Holdings Sees Relative Strength Rating Jump To 92 - MSN
Ginkgo Bioworks Holdings Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Ginkgo Bioworks Holdings Earns Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):